← Evidence map

ReviewJournal of comparative effectiveness research2023

Navigating adalimumab biosimilars: an expert opinion.

Vered Abitbol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37855223